Sign In
Buy PJP
$106.48
+0.370 (+0.349%)
At Close: Jun 03, 2026
A Look at Pharma ETFs After Q4 Earnings
02:01pm, Monday, 12'th Feb 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs re
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
07:31am, Thursday, 21'st Dec 2023
The Invesco Pharmaceuticals ETF (PJP) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
07:31am, Tuesday, 28'th Nov 2023
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on 06/23/2005.
Pharma ETFs in Focus Post Q3 Earnings
12:46pm, Wednesday, 08'th Nov 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
07:31am, Thursday, 19'th Oct 2023
A smart beta exchange traded fund, the Invesco Pharmaceuticals ETF (PJP) debuted on 06/23/2005, and offers broad exposure to the Health Care ETFs category of the market.
Where to Find Value Among Pharma Stocks
12:44pm, Monday, 02'nd Oct 2023
Healthcare, the second-largest sector allocation in the S&P 500, is often viewed through the lens of defensive and value traits. The latter scenario is being amplified this year, as the S&P 500 Health
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
07:31am, Monday, 25'th Sep 2023
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on 06/23/2005.
Time for Gilead Sciences-Heavy ETFs?
03:05pm, Tuesday, 12'th Sep 2023
Bank of America expects the Gilead Sciences to jump about 30%, as quoted on CNBC.
This Week in ETFs: Invesco Makes Changes to 35 Funds
07:33pm, Friday, 01'st Sep 2023
A total of nine funds launched during the week ending Sept. 1, thus a dip after the 17 ETF launches last week but not unusual in the leadup to a holiday weekend.
Biden touts drug-price program as ‘new deal for patients,' while Republicans blast ‘government overreach'
02:52pm, Tuesday, 29'th Aug 2023
President Joe Biden on Tuesday pledged to “keep standing up to Big Pharma,” as he celebrated his administration's rollout of the first 10 drugs to be selected for a price-negotiation program.
Pharma ETFs in Focus Post Q2 Earnings
01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.
5 Sector ETF Winners Amid Q2 Earnings Season
10:01am, Thursday, 10'th Aug 2023
It has been almost a month since the second-quarter earnings season kicked off. These sectors emerged winners so far in this earnings season.
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?
07:52am, Tuesday, 25'th Jul 2023
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the Invesco Dynamic Pharmaceuticals ETF (PJP), a passively managed exchange traded
PJP: Concentrating On Large-Cap Biopharmaceuticals Seems To Be A Bad Strategy
05:28pm, Monday, 17'th Jul 2023
55 percent of Invesco Dynamic Pharmaceuticals ETF's investment is in ten giant-capitalized and large-capitalized biopharmaceutical stocks which delivered poor returns over the long run. 18 blockbuster
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
03:37pm, Thursday, 22'nd Jun 2023
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
